132 related articles for article (PubMed ID: 9696394)
1. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential.
Jackson JG; Yoneda T; Clark GM; Yee D
Clin Cancer Res; 2000 Mar; 6(3):1135-9. PubMed ID: 10741744
[TBL] [Abstract][Full Text] [Related]
4. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.
Davol PA; Bagdasaryan R; Elfenbein GJ; Maizel AL; Frackelton AR
Cancer Res; 2003 Oct; 63(20):6772-83. PubMed ID: 14583473
[TBL] [Abstract][Full Text] [Related]
5. Agonist-mediated tyrosine phosphorylation of isoforms of the shc adapter protein by the delta opioid receptor.
Mullaney I; Carr IC; Burt AR; Wilson M; Anderson NG; Milligan G
Cell Signal; 1997 Sep; 9(6):423-9. PubMed ID: 9376223
[TBL] [Abstract][Full Text] [Related]
6. p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
Frackelton AR; Lu L; Davol PA; Bagdasaryan R; Hafer LJ; Sgroi DC
Breast Cancer Res; 2006; 8(6):R73. PubMed ID: 17196107
[TBL] [Abstract][Full Text] [Related]
7. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells.
Sato K; Kimoto M; Kakumoto M; Horiuchi D; Iwasaki T; Tokmakov AA; Fukami Y
Genes Cells; 2000 Sep; 5(9):749-64. PubMed ID: 10971656
[TBL] [Abstract][Full Text] [Related]
8. c-Src and phosphatidylinositol 3-kinase are involved in NGF-dependent tyrosine phosphorylation of Shc in PC12 cells.
Sato K; Otsuki T; Kimoto M; Kakumoto M; Tokmakov AA; Watanabe Y; Fukami Y
Biochem Biophys Res Commun; 1998 Sep; 250(2):223-8. PubMed ID: 9753611
[TBL] [Abstract][Full Text] [Related]
9. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
Yoshida S; Masaki T; Feng H; Yuji J; Miyauchi Y; Funaki T; Yoshiji H; Matsumoto K; Uchida N; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2004 Oct; 25(4):1089-96. PubMed ID: 15375560
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
Lee MS; Igawa T; Lin MF
Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
[TBL] [Abstract][Full Text] [Related]
12. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
[TBL] [Abstract][Full Text] [Related]
13. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas.
Lee MS; Igawa T; Chen SJ; Van Bemmel D; Lin JS; Lin FF; Johansson SL; Christman JK; Lin MF
Int J Cancer; 2004 Feb; 108(5):672-8. PubMed ID: 14696093
[TBL] [Abstract][Full Text] [Related]
14. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
15. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
16. Neuregulin-increased expression of acetylcholine receptor epsilon-subunit gene requires ErbB interaction with Shc.
Won S; Si J; Colledge M; Ravichandran KS; Froehner SC; Mei L
J Neurochem; 1999 Dec; 73(6):2358-68. PubMed ID: 10582594
[TBL] [Abstract][Full Text] [Related]
17. Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signaling.
Faisal A; el-Shemerly M; Hess D; Nagamine Y
J Biol Chem; 2002 Aug; 277(33):30144-52. PubMed ID: 12052829
[TBL] [Abstract][Full Text] [Related]
18. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells.
Foschi M; Franchi F; Han J; La Villa G; Sorokin A
J Biol Chem; 2001 Jul; 276(28):26640-7. PubMed ID: 11342545
[TBL] [Abstract][Full Text] [Related]
20. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
